ADVICENNE (PROM.) EO-,20

Share · FR0013296746 · A2H8SU (XPAR)

Overview

No Price

Closing Price XPAR 05.11.2025: 1,69 EUR

05.11.2025 08:54

Current Prices from ADVICENNE (PROM.) EO-,20

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
Paris	ALDVI.PA	EUR	05.11.2025 08:54	1,69 EUR	-0,04 EUR -2,09 %

Company Profile for ADVICENNE (PROM.) EO-,20 Share

Advicenne S.A. develops therapeutics for the treatment of rare kidney diseases. Its lead product candidate is ADV7103 for the treatment of distal renal tubular acidosis in children and adults, as well as for the treatment of cystinuria, an inherited renal tubulopathy. The company also provides ADV6209, an oral liquid solution for children to reduce anxiety and to improve their immobility. Advicenne S.A. was founded in 2007 and is based in Paris, France.

Get up to date insights from finAgent about ADVICENNE (PROM.) EO-,20

Company Data

Name ADVICENNE (PROM.) EO-,20

Company Advicenne S.A.

Website https://www.advicenne.com

Primary Exchange

Paris

WKN A2H8SU

ISIN FR0013296746

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Andr Ulmann

Country France

Currency EUR

Employees 0,0 T

Address 2 Rue Briconnet, 75002 Nimes

IPO Date 2017-12-06

Ticker Symbols

Name	Symbol
Frankfurt	3MM.F
Paris	ADVIC.PA
Paris	ALDVI.PA

More Shares

Investors who hold ADVICENNE (PROM.) EO-,20 also have the following shares in their portfolio:

NEUREN PHARMACEUTICALS Share

POWERCHIP TECHNOLOGY CORPORATION - GDS (EACH REPR 10 TWD10)(144A) Depository Receipt

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog